Documents R DEVELOPMENT PROGRAM & STUDY RESULTS Slide # 31.

Slide 1r DEVELOPMENT PROGRAM & STUDY RESULTS Slide # 31 Slide 2 r IV GANCICLOVIR u IV GCV is a first-line treatment for CMVR u Approved in US in 1989 u Current Indications…

Documents Sivextro ™ (tedizolid phosphate) Manufacturer: Cubist Pharmaceuticals FDA Approval Date: June 20,....

Slide 1 Sivextro ™ (tedizolid phosphate) Manufacturer: Cubist Pharmaceuticals FDA Approval Date: June 20, 2014 Slide 2 Indications: Acute bacterial skin and skin structure…